Hysbysiad dyfarnu contract
Canlyniadau'r weithdrefn gaffael
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
Public Health England
Public Health England, Wellington House , 133-155 Waterloo Road, London
London
SE1 8UG
UK
E-bost: bravo@phe.gov.uk
NUTS: UKI
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://www.gov.uk/government/organisations/public-health-england
I.4) Y math o awdurdod contractio
Gweinyddiaeth neu unrhyw awdurdod cenedlaethol neu ffederal arall, gan gynnwys eu his-adrannau rhanbarthol neu leol
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
PHE - Breast Cancer Test and Training System
Cyfeirnod: project_1325; ecm_7236
II.1.2) Prif god CPV
48780000
II.1.3) Y math o gontract
Cyflenwadau
II.1.4) Disgrifiad byr
Breast cancer screening system
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.1.7) Cyfanswm gwerth y caffaeliad
Gwerth heb gynnwys TAW: 505 614.00 GBP
II.2) Disgrifiad
II.2.3) Man cyflawni
Cod NUTS:
UKZ
II.2.4) Disgrifiad o’r caffaeliad
The contracts supports the Breast Cancer Screening Programme. The aim of the Programme is to maximise screening sensitivity (diagnosing the disease in the population who have the disease) whilst also maximising screening specificity (correctly identifying those who do not have the disease).
II.2.5) Meini prawf dyfarnu
Price
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Ydy
Disgrifiad o’r opsiynau:
Extension 0f contract for one year beyond initial contract term.
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Dyfarnu contract heb gyhoeddi galwad am gystadleuaeth yng Nghyfnodolyn Swyddogol yr Undeb Ewropeaidd ymlaen llaw
Cyfiawnhau'r weithdrefn ddyfarnu a ddewiswyd:
Mae’r caffaeliad y tu allan i gwmpas cymhwysiad y gyfarwyddeb
Esboniad
PHE originally went out to market using the open procedure with only one tenderer (the existing supplier) expressing an interest. Subsequently that tenderer notified PHE that they could no longer fulfil the requirements of the specification due to a key member of staff moving to the University of Nottingham. The tenderer subsequently transferred the intellectual property to the University of Nottingham to help facilitate the continuance of programme monitoring.
The University of Nottingham have agreed to meet the specification requirements at the same cost as the bidder that originally tendered therefore ensuring value for money.
As there is only one supplier capable of meeting the requirements PHE used the negotiated procedure without prior publication to award the contract to the University of Nottingham under Regulations 32 (2) (b) (ii) and (iii).
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
IV.2) Gwybodaeth weinyddol
IV.2.1) Cyhoeddiad blaenorol mewn perthynas â’r weithdrefn hon
Rhif yr hysbysiad yn OJ S:
2018/S 156-358478
Section V: Dyfarnu contract
Rhif Contract: ecm_7236
Teitl: PHE - Breast Cancer Test and Training System
Dyfernir contract/lot:
Ydy
V.2 Dyfarnu contract
V.2.1) Y dyddiad y daeth y contract i ben
02/03/2020
V.2.2) Gwybodaeth am dendrau
Nifer y tendrau a ddaeth i law: 1
Dyfarnwyd y contract i gr?p o weithredwyr economaidd:
Na
V.2.3) Enw a chyfeiriad y contractwr
The University of Nottingham
University Park
Nottingham
NG7 2RD
UK
NUTS: UKF14
BBaCh yw’r contractwr:
Na
V.2.4) Gwybodaeth am werth y contract/lot (heb gynnwys VAT)
Cyfanswm gwerth y contract/lot: 505 614.00 GBP
V.2.5) Gwybodaeth am is-gontractio
Section VI: Gwybodaeth ategol
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
UK Health Security Agency
Nobel House, 17 Smith Square
London
SW1P 3JR
UK
VI.5) Dyddiad anfon yr hysbysiad hwn
08/04/2022